ARA290 Improves Insulin Release and Glucose Tolerance in Type 2 Diabetic Goto-Kakizaki Rats
Carole Muller(Karolinska University Hospital), Claes‐Göran Östenson(Karolinska Institutet), Michael Brines(Northwell Health), Luo-Sheng Li(Karolinska University Hospital), Suad Efendić(Karolinska University Hospital), Magnus Palmblad(Leiden University Medical Center), Per‐Olof Berggren(Karolinska Institutet), Kamal Yassin(Karolinska University Hospital), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 13
Related Papers
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
|The Lancet Oncology|2013|1.6k
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
|Journal of the American College of Cardiology|1995|1.6k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k